MDCX
Medicus Pharma Ltd. Common StockHealthcare · $3M market cap
Verdict
We can't put a fair value on MDCX right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow MDCX
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 4, 2026: no open-market purchases and 10 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
Bokhari Raza
Chief Executive Officer · 2026-09-04
Award
$85K
Bokhari Raza
Chief Executive Officer · 2026-09-04
Award
$501K
Bonner Carolyn F.
President and CFO · 2026-09-04
Award
$43K
Bonner Carolyn F.
President and CFO · 2026-09-04
Award
$251K
Brennan Edward J.
Chief Scientific Officer · 2026-09-04
Award
$17K
Show all 10 other filingsShow fewer
Brennan Edward J.
Chief Scientific Officer · 2026-09-04
Award
$100K
Mehmud Faisal
Chief Medical Officer · 2026-09-04
Award
$43K
Mehmud Faisal
Chief Medical Officer · 2026-09-04
Award
$251K
Smith Andrew Alasdair
Chief Operating Officer · 2026-09-04
Award
$21K
Smith Andrew Alasdair
Chief Operating Officer · 2026-09-04
Award
$125K
About Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works